Myr5A Peptide

Send Inquiry
Myr5A Peptide
Details
•CAS: Not specified
•Synonyms: Myr5A peptide; Myristoylated 5A peptide; ApoA1 mimetic peptide; HDL-mimetic nanoparticle
•Core structure: Myristoylated amphipathic α-helical peptide with sequence {Myr}-Asp-Trp-Leu-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Leu-Lys-Glu-Ala-Phe-Pro-Asp- (Myr-5A), with a tetradecanoic acid (myristic acid, Myr) attached to the N-terminal aspartic acid side chain. A myristoylated derivative of apolipoprotein A1 (ApoA1) mimetic peptide 5A, self-assembles into high-density lipoprotein (HDL)-mimetic lipid nanostructures, used for encapsulation of anthracycline drugs (such as doxorubicin, valrubicin) and drug release studies.
•We also provide specifications from crude to 99% purity. Please contact us for details!
Related documents
•COA/MS/HPLC Report
•Peptide Dissolution and Storage Guide
Category
Drug Delivery Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of myr5a peptide in China, also supports custom service. Welcome to wholesale bulk high quality myr5a peptide from our factory. Contact us for more details.

 

Product Name Myr5A peptide
Description Myr5A peptide (Myr5A peptide) is a myristoylated derivative of apolipoprotein A1 (ApoA1) mimetic peptide 5A, an amphipathic α-helical lipopeptide. Peptide 5A is a rationally designed ApoA1 mimetic peptide composed of 22 amino acids, with an amphipathic α-helical structure that mimics the lipid-binding and reconstituted high-density lipoprotein (rHDL) formation ability of ApoA1. Myr5A introduces a hydrophobic lipid tail by covalently attaching myristic acid (tetradecanoic acid, C14) to the side-chain carboxyl group of the N-terminal aspartic acid of peptide 5A, forming an amphipathic molecule composed of a hydrophilic peptide segment and a hydrophobic myristoyl group. Circular dichroism (CD) measurements indicate that myristic acid conjugation does not alter the α-helical secondary structure of peptide 5A. In aqueous solution, Myr5A can self-assemble through hydrophobic interactions and α-helical packing of peptide chains to form discoidal or spherical high-density lipoprotein (HDL)-mimetic lipid nanostructures, structurally similar to native HDL with a phospholipid bilayer core and outer peptide shell. These HDL-mimetic nanoparticles can be used to encapsulate hydrophobic drugs, particularly anthracycline chemotherapeutics such as doxorubicin and valrubicin, through interactions between the drug and the hydrophobic core of the nanoparticle, and for in vitro drug release kinetics studies. Myr5A self-assembled nanoparticles can also utilize HDL receptor (such as SR-BI, ABCA1)-mediated cellular uptake pathways for targeted drug delivery, with potential applications in cardiovascular disease therapy (such as anti-inflammation, reverse cholesterol transport) and tumor-targeted therapy. In addition, the intrinsic fluorescence of tryptophan and tyrosine residues in Myr5A peptide can be used to probe the assembly process and structural changes of nanoparticles.
Peptide Purity (HPLC, %) ≥95%
Molecular formula C₂₁₁H₃₂₁N₄₇O₅₇
Molecular weight (Da) 4428.09

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Myr5A peptide Myristoyl pentaalanine peptide; membrane-anchoring peptide Myr5A Membrane localization peptide, protein membrane anchoring, liposome modification, cell membrane engineering N-terminal myristoylated (C14 saturated fatty acid) pentaalanine; myristoyl is a natural membrane-targeting group that inserts into phospholipid bilayers for protein anchoring, liposome functionalization and membrane engineering C₂₈H₅₃N₅O₆ 555.4 ~555.7 Free peptide (lipid-modified) 5 (pentapeptide + myristoyl)

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-MY5001 White to off-white crystalline powder Store at -20°C, sealed, dry and protected from light. Aliquot for storage. Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. Stable for 7 days at 4°C. Lipid-modified peptide is soluble in chloroform, DMSO, ethanol and lipid systems. Almost insoluble in water; inserts into phospholipid bilayers with strong membrane-binding activity. Stable for 2 years at -20°C, dry and protected from light.

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-MY5001 Myristoyl pentapeptide Myr5A, natural membrane anchor for cell membrane & liposome Myr5A is a myristoylated pentaalanine peptide. Myristoyl is a naturally occurring post-translational modification in eukaryotes that stably inserts into phospholipid bilayers via hydrophobic interaction to achieve membrane anchoring of proteins or nanoparticles. It is widely used in protein membrane localization modification, liposome surface functionalization, cell membrane engineering and membrane protein reconstitution research. Cell membrane engineering, protein lipid modification, liposome technology, membrane protein research, biomembrane biomimetics Phospholipid bilayer hydrophobic insertion; membrane anchoring modification; liposome surface functionalization

 

 

 

 

 

 

 

 

 

 

 

 

Hot Tags: myr5a peptide, China myr5a peptide manufacturers, suppliers, factory, 191936-91-1, 395069-92-8, 997-20-6, CAS 191936 91 1, NGR peptide, therapeutic and pharmaceutical peptides

Send Inquiry